Multiple sclerosis in Italy: cost-of-illness study.
Neurol Sci
; 32(5): 787-94, 2011 Oct.
Article
em En
| MEDLINE
| ID: mdl-21409509
ABSTRACT
This study estimates the direct costs of multiple sclerosis (MS) in Italy from the perspective of the National Health System. Patients diagnosed with MS for ≥1 year prior to study entry were included in the analysis; neurological disability was assessed using the Expanded Disability Status Scale (EDSS). Cost variables were analyzed according to MS phenotype, disease course over the previous year and EDSS rating. A total of 510 patients were included in the analysis. Overall costs were significantly higher for relapsing-remitting MS and secondary progressive MS than for primary progressive MS (P < 0.05). Costs were higher for EDSS scores 0.0-3.5 and 4.0-6.0 than for scores > 6.0 (P < 0.05). The extrapolated data gave an estimated annual direct cost of MS per patient of
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Custos de Cuidados de Saúde
/
Efeitos Psicossociais da Doença
/
Esclerose Múltipla
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article